tiprankstipranks
Relay Therapeutics (RLAY)
NASDAQ:RLAY
US Market

Relay Therapeutics (RLAY) Financial Statements

Compare
455 Followers

Relay Therapeutics Financial Overview

Relay Therapeutics's market cap is currently $461.10M. The company's EPS TTM is $-2.398; its P/E ratio is ―; Relay Therapeutics is scheduled to report earnings on February 20, 2025, and the estimated EPS forecast is $-0.52. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 10.01M$ 25.55M$ 1.38M$ 3.03M$ 82.65M
Gross Profit$ 10.01M$ 20.28M$ -2.75M$ -896.00K$ 79.11M
Operating Income$ -372.47M$ -373.00M$ -299.27M$ -364.70M$ -55.80M
EBITDA$ -380.21M$ -374.15M$ -306.82M$ -222.18M$ -52.25M
Net Income$ -337.71M$ -341.97M$ -254.26M$ -496.81M$ -49.01M
Balance Sheet
Cash & Short-Term Investments$ 781.32M$ 750.09M$ 998.92M$ 958.07M$ 678.06M
Total Assets$ 871.30M$ 843.98M$ 1.10B$ 1.01B$ 799.83M
Total Debt$ 48.50M$ 53.47M$ 57.74M$ 22.90M$ 24.42M
Net Debt$ -75.78M$ -90.27M$ -941.17M$ -935.17M$ -423.22M
Total Liabilities$ 93.50M$ 91.98M$ 149.55M$ 110.64M$ 36.54M
Stockholders' Equity$ 777.79M$ 752.00M$ 950.22M$ 897.81M$ 763.29M
Cash Flow
Free Cash Flow$ -251.13M$ -304.44M$ -238.55M$ -77.88M$ -104.42M
Operating Cash Flow$ -249.11M$ -300.32M$ -229.49M$ -74.41M$ -102.49M
Investing Cash Flow$ -41.08M$ 257.63M$ -188.75M$ -479.51M$ 81.67M
Financing Cash Flow$ 270.15M$ 34.75M$ 289.91M$ 388.09M$ 426.51M
Currency in USD

Relay Therapeutics Earnings and Revenue History

Relay Therapeutics Debt to Assets

Relay Therapeutics Cash Flow

Relay Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis